US Patent RE42324 Compound for treatment of allergy and asthma

Patent RE42324 was granted and assigned to Phadia on May, 2011 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

‌

Phadia

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

RE42324

Patent Inventor Names

Wolfgang R. Sperr0

Peter Valent0

Rudolf Valenta0

Sylvia Laffer0

Dietrich Kraft0

Erik Hogbom0

Hans Grönlund0

Jonas Adriansson0

...

Date of Patent

May 3, 2011

Patent Application Number

12757821

Date Filed

April 9, 2010

Patent Primary Examiner

‌

Phuong Huynh

Patent abstract

The present invention relates to a novel drug candidate having a potential for universal therapy of allergy and asthma.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent RE42324 Compound for treatment of allergy and asthma

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API